Mapping the Geographic Distribution of Dimorphic Mycoses Using a US Commercial Insurance Database
New diagnoses of histoplasmosis, coccidioidomycosis, and blastomycosis were routinely made outside their historically defined regions of endemicity. While exposure to hyperendemic regions remains a risk factor for developing a DM infection, clinicians should consider testing any patient presenting with a compatible clinical syndrome, regardless of their geographic history. Increased suspicion of DM infection will lead to fewer missed or delayed diagnoses, thereby improving patient outcomes.
Authors
- Julio Cesar Zuniga-Moya (ORCID: https://orcid.org/0000-0002-8561-5463)
- Patrick B Mazi (ORCID: https://orcid.org/0000-0003-4123-0518)
- Andrej Spec (ORCID: https://orcid.org/0000-0001-7612-4710)
- Reid Goodman
- Adriana M. Rauseo (ORCID: https://orcid.org/0000-0001-9555-2550)
- William G. Powderly (ORCID: https://orcid.org/0000-0001-7808-3086)
- Samuel L Windham
Institutions
- University of Kansas (US)
- Washington University in St. Louis (US)
- The University of Kansas Health System (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/ofid/ofae755
- Citations
- 5
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Gilead Sciences
- Institute of Clinical and Translational Sciences
- Cidara Therapeutics
- Astellas Pharma
- National Institutes of Health
- National Center for Advancing Translational Sciences